Evaluation of Choline Chloride for Intestinal Failure Patients Receiving Long-Term Parenteral Support
- Substances:–
Germany- Participants:0–17 years · 18–64 years · 65+ years
- Sponsor:Protara Therapeutics Inc.
Rare diseases
Investigational molecules
Locations
Back to Germany607 clinical trials in Tuebingen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
GermanyEfficacy of 177Lu-DOTATATE as Adjuvant Therapy After Surgery for Stage III Small Intestinal Neuroendocrine Tumors
GermanyStudy of Temozolomide, Topotecan, Bevacizumab, Irinotecan and Dinutuximab Beta in Patients with High-Risk Relapsed Neuroblastoma
GermanyVusolimogene Oderparepvec with Nivolumab for Advanced Melanoma Patients Whose Cancer Progressed After Previous Immunotherapy Treatments
GermanyStudy on the Safety and Effectiveness of Sovateltide for Patients with Acute Ischemic Stroke
GermanyStudy on the Safety and Effectiveness of Patritumab Deruxtecan for Children with Relapsed or Refractory Hepatoblastoma and Rhabdomyosarcoma
GermanyStudy on Pembrolizumab and Drug Combination for Patients with Recurrent Head and Neck Cancer
GermanyEvaluation of remibrutinib (LOU064) effectiveness and safety in adult patients with chronic urticaria: A 12-week placebo-controlled study
GermanyStudy Comparing Zilovertamab Vedotin with Drug Combination for Untreated Patients with Diffuse Large B-Cell Lymphoma
GermanyStudy on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn's Disease
GermanyStudy on Long-term Safety and Efficacy of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
GermanyStudy on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Previously Used Biologic Treatments
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on cutaneous lupus erythematosus and psoriatic arthritis, evaluating novel therapeutic approaches for managing chronic inflammatory conditions.
Studies aim to assess new treatment options for improving patient outcomes and quality of life.
Comprehensive studies on various cancer types, including metastatic prostate cancer and basal cell carcinoma, exploring innovative treatment combinations.
Research focuses on improving survival rates and developing more effective treatment strategies.
Groundbreaking research in multiple system atrophy and seizure disorders, investigating new therapeutic approaches for complex neurological conditions.
Clinical trials aim to enhance treatment options for patients with challenging neurological conditions.
Advanced research in eye disorders, including Leber congenital amaurosis and geographic atrophy, focusing on innovative treatment approaches.
Trials aim to preserve and improve vision in patients with rare and progressive eye conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.